About Hudson Institute of Medical Research

Pharmorage has a strong strategic partnership with Hudson Institute of Medical Research, which has led to the development of novel molecules with potential applications in improving mRNA vaccine technologies and in treating autoimmune diseases.

Hudson Institute is a global leader in discovery and translational medical research, focused on powering breakthrough scientific discoveries into improved health care to transform lives. The team strives to improve human health through groundbreaking, collaborative medical research discoveries.

Pharmorage has exclusive rights to commercialise any technologies that stem from this partnership.

Hudson Institute houses Australia’s largest group of inflammation researchers and is establishing the world-leading National Centre for Inflammation Research (NCIR) within the Institute.

Hudson Institute’s Associate Professor Michael Gantier has extensive expertise in the regulation of innate immunity by nucleic acids, and is working closely with Pharmorage and Noxopharm in drug discovery and development.